Giant Biogene Reports First Revenue and Profit Decline Since IPO
Giant Biogene posted its first post-IPO decline in revenue and net profit as it shifts away from influencer livestreams toward medical injectables.
Archive
Tag: Medical Aesthetics
Vitality Institute Reaches 20 Million VI Peel Treatments Without Outside Capital
Vitality Institute CEO Marya Khalil-Otto reflects on reaching 20 million VI Peel treatments while remaining bootstrapped and profitable.
L'Oréal-Backed Aesthetics Chain Yesskin Named Debtor in Chinese Court Order
L'Oréal-backed medical aesthetics chain Yesskin faces an 881,600 RMB court enforcement in China as its retail skincare revenues soften.
Giant Biogene Shuts Down Nutricosmetics Venture to Refocus on Medical Aesthetics
Giant Biogene has shuttered its SKIGIN joint venture, shifting resources from nutricosmetics to high-margin recombinant collagen medical devices.